Search
for
Sort by
Research 301–330 of 1000+
- Elevated Ghrelin Plasma Levels in Patients with Polycystic Ovary Syndrome
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- The role of androgens in hormone replacement therapy
- Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series
- Elevated Dehydroepiandrosterone Sulfate Levels as the Reproductive Phenotype in the Brothers of Women with Polycystic Ovary Syndrome
- Androgens and the Menopause
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Androgen Levels and Body Size Are Associated with Directional as Well as Fluctuating Asymmetry Patterns in Adult !Kung San and Kavango Males from Northern Namibia
- The therapeutic use of androgens in women
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Gender Differences in Production and Circulating Levels of Sex Hormones and Their Impact on Aging Skin
- SUN-195 Falsely Elevated Testosterone Levels: Role of LC-MS/MS in Reducing Unnecessary Testing
- The influence of long-term treatment with cyproterone acetate or a cyproterone acetate-ethinyl oestradiol combination on androgen levels in blood of hirsute women
- Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels
- Role of serum androgens and prostate-specific antigen levels in men with androgenetic alopecia
- Vitmain D level in female pattern hair loss with normal androgen level
- Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels
- SAT-293 Novel Presentation Of A Heterozygous INSR Mutation And Markedly Elevated Testosterone Levels In A Pediatric Patient, A Case Report.
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
- Treatment of hyperandrogenism in polycystic ovary syndrome
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- New onset alopecia and hirsutism in a postmenopausal women
- Vitamin B<sub>3</sub> (niacin), B<sub>6</sub>, C, and iron intake are associated with the free androgen index, especially in normoandrogenic polycystic ovary syndrome
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Skin manifestations of endocrine diseases
- Rotterdam criteria–based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth